Actively Recruiting
Colo-Pro_2: Bolus-continuous Infusion Cefuroxime Prophylaxis for the Prevention of Infections After Colorectal Surgery
Led by University of Leeds · Updated on 2024-05-08
180
Participants Needed
3
Research Sites
103 weeks
Total Duration
On this page
Sponsors
U
University of Leeds
Lead Sponsor
U
University of Birmingham
Collaborating Sponsor
AI-Summary
What this Trial Is About
After a surgical operation patients may have an infection in the operation wound, the bladder, kidneys or lungs. To stop these infections patients are given a dose of antibiotic before their operation. Unfortunately, the amount of antibiotic available to fight infections falls throughout an operation, being removed from the body by the kidneys. Therefore, antibiotic levels may not be high enough to stop infections. A way of maintaining antibiotic levels throughout an operation is to give a single dose of antibiotic and then a constant amount of antibiotic by an infusion from the start to the end of the operation. A small single centre test study was previosuly undertaken into antibiotic dosing during bowel operations. One group of patients had a single dose of antibiotic before their operation. The other group had a single dose plus a constant dose of antibiotic until the end of their operation. The project showed patients were happy to take part and that the study was safe. The study helped us identify the correct amounts of antibiotic needed for the patients given the single dose plus a constant dose of antibiotic. This study was conducted at one hospital only, and wasn't big enough to confirm if one treatment was better than another or if results would be similar in other hospitals. This study will build on the pilot study in a larger feasibility trial, the Colo-Pro\_2 trial. It will be run in three hospitals so can assess if the trial design works at different hospitals. We will see if the results suggest one treatment, single dose of antibiotics before an operation, or single dose plus a constant dose of antibiotics throughout an operation, is better. This study will include up to 180 patients having bowel operations as they have a high risk of infection. All patients will be given the same antibiotic which is called cefuroxime. Cefuroxime is already used to stop infections after surgery. Using the same antibiotic in all patients means it is possible to know if differences in the number of infections are due to how the antibiotic is given. The number of infections that happen up to 30 days after operations will be counted. Staff looking after patients after the operation and those counting the infections will not know, unless necessary, the treatment patients received. This means the results won't be influenced by knowledge of the treatment received.
CONDITIONS
Official Title
Colo-Pro_2: Bolus-continuous Infusion Cefuroxime Prophylaxis for the Prevention of Infections After Colorectal Surgery
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Undergoing elective colorectal surgery involving incision, excision, or anastomosis of the large bowel, including small to large bowel anastomosis
- Age over 16 years
- Expected surgery duration longer than 2 hours
- Creatinine clearance greater than 40 ml/min
- Cefuroxime or metronidazole are suitable antibiotic prophylaxis options
- Able to give informed consent
- Patients having colorectal surgery combined with additional surgeries such as plastic, urological, or gynecological surgery
You will not qualify if you...
- Unable to provide informed consent
- Pregnant at time of surgery
- Expected surgery duration less than 2 hours
- Creatinine clearance below 40 ml/min
- Individual microbiological advice recommending non-cefuroxime prophylaxis
- Allergy to cephalosporins
- Penicillin allergy with hypersensitivity reaction
- Taking coumarin medications like warfarin or acenocoumarol
- History of seizures or epilepsy
- Using probenecid
- Currently participating in research aimed at reducing surgical site infections
- Receiving antibiotics for systemic Gram-negative infection within 12 hours before surgery (except certain allowed antibiotics)
- Having an active infection at study entry
- Undergoing stapled trans anal resection of the rectum (STARR procedure)
- Weight less than 30 kg or more than 110 kg
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 3 locations
1
TheUniversity of Birmingham
Birmingham, West Midlands, United Kingdom, B15 2TT
Not Yet Recruiting
2
Leeds Teaching Hospitals
Leeds, West Yorkshire, United Kingdom, LS17 9EJ
Actively Recruiting
3
Aneurin Bevan University Health Board
Newport, United Kingdom, NP20 2UB
Actively Recruiting
Research Team
A
Andrew Kirby
CONTACT
D
Dermot Burke
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
QUADRUPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here